scholarly journals Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy

2017 ◽  
Vol 28 ◽  
pp. v81
Author(s):  
N.M. Iyengar ◽  
L.M. Smyth ◽  
D. Lake ◽  
A. Gucalp ◽  
J.C. Singh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Her2 Positive

Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-Positive metastatic breast cancer (MBC) after prior HP- or TDM/P-based therapy.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 611-611
Author(s):  
Neil M. Iyengar ◽  
Lillian Mary Smyth ◽  
Maxine S. Jochelson ◽  
Diana Lake ◽  
Ayca Gucalp ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Her2 Positive
Sign in / Sign up

Export Citation Format

Share Document